The Affymetrix CytoScan HD Array interrogates the entire genome using more than 2.6 million markers for copy-number analysis and approximately 750,000 SNPs. The platform offers excellent ...

Recently, Affymetrix Corporation developed an array (CytoScan-HD) that consists of 2.7 million probes. Although these cover the entire genome, the densest representation is within genes ...

Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since the early 1990s, has grown to become much more than a microarray innovator. Through ...

Hamilton Robotics has announced that the soon-to-launch CytoScan Automated Target Preparation Solution from Affymetrix, Inc. is built on the customizable Microlab® NIMBUS 96 workstation from Hamilton ...

Affymetrix gained the FDA's OK for its CytoScan Dx Assay, a first-of-its-kind blood test that can identify possible genetic causes behind a child's developmental delay or intellectual disability.

The prevalence of developmental disabilities in the United States is reported to be 13.87% across all racial, ethnic, and socioeconomic groups. Microarrays have been recommended as first-tier ...